For people with diabetes, there is also a risk of diabetic retinopathy progression, particularly with rapid improvement in blood glucose control
Constipation is particularly prevalent and can be exacerbated by reduced food and fluid intake
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management (weight loss and weight maintenance) in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or greater (obesity) or 27 kg/m 2 or greater (excess weight) in the presence of at least one weight related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Mol Neurobiol 55(4):34993512 Yardmolu M, Ilbay G, Kktrk S, Onar FD, ahin D, Alkan F, Dalcik H (2007) Light and Electron microscopic examinations in the Hippocampus of the rat brain following PTZ-Induced epileptic seizures Yu AS, Hirayama BA, Timbol G, Liu J, Diez-Sampedro A, Kepe V, Satyamurthy N, Huang S-C, Wright EM, Barrio JR (2013) Regional distribution of SGLT activity in rat brain in vivo
Is compounded semaglutide as effective as brand-name Ozempic or Wegovy
It has been proposed that damage caused by ROS and RNS including HNE causes impaired glucose metabolism and electrochemical gradients across membranes which in turn affects calcium homeostasis (Butterfield and Halliwell 2019)
